| Dr Bradley Philip Oneill, DO | |
|
148 13th St Sw, Largo, FL 33770-3127 | |
| (727) 581-8706 | |
| (727) 588-2447 |
| Full Name | Dr Bradley Philip Oneill |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 11 Years |
| Location | 148 13th St Sw, Largo, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043646672 | NPI | - | NPPES |
| 1043646672 | Other | PA | NPI |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Eye Associates Of Manatee, Llp | 4688664535 | 39 |
News Archive
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today celebrated the completion of renovations to its U.S. headquarters in Bridgewater, New Jersey with a ribbon-cutting ceremony.
Oncolytics Biotech Inc. announced today that enrollment has begun in a 2-Arm randomized Phase II study of carboplatin, paclitaxel plus REOLYSIN versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer.
Two community dental clinics that provide much-needed services to low-income people who lack access to care will receive a $10,000 grant from Delta Dental of Pennsylvania.
In a study to be presented on February 16 between 8 a.m., and 10 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, researchers will report findings that suggest comprehensive maternal hemorrhage protocols reduce utilization of blood products and improve patient safety.
› Verified 3 days ago
| Entity Name | Eye Centers Of Florida |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831286202 PECOS PAC ID: 0749187847 Enrollment ID: O20031217000271 |
News Archive
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today celebrated the completion of renovations to its U.S. headquarters in Bridgewater, New Jersey with a ribbon-cutting ceremony.
Oncolytics Biotech Inc. announced today that enrollment has begun in a 2-Arm randomized Phase II study of carboplatin, paclitaxel plus REOLYSIN versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer.
Two community dental clinics that provide much-needed services to low-income people who lack access to care will receive a $10,000 grant from Delta Dental of Pennsylvania.
In a study to be presented on February 16 between 8 a.m., and 10 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, researchers will report findings that suggest comprehensive maternal hemorrhage protocols reduce utilization of blood products and improve patient safety.
› Verified 3 days ago
| Entity Name | The Eye Associates Of Manatee, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366483851 PECOS PAC ID: 4688664535 Enrollment ID: O20040513001080 |
News Archive
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today celebrated the completion of renovations to its U.S. headquarters in Bridgewater, New Jersey with a ribbon-cutting ceremony.
Oncolytics Biotech Inc. announced today that enrollment has begun in a 2-Arm randomized Phase II study of carboplatin, paclitaxel plus REOLYSIN versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer.
Two community dental clinics that provide much-needed services to low-income people who lack access to care will receive a $10,000 grant from Delta Dental of Pennsylvania.
In a study to be presented on February 16 between 8 a.m., and 10 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, researchers will report findings that suggest comprehensive maternal hemorrhage protocols reduce utilization of blood products and improve patient safety.
› Verified 3 days ago
| Entity Name | St. Lucy's Outpatient Surgery Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1326047101 PECOS PAC ID: 0749332633 Enrollment ID: O20090724000064 |
News Archive
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today celebrated the completion of renovations to its U.S. headquarters in Bridgewater, New Jersey with a ribbon-cutting ceremony.
Oncolytics Biotech Inc. announced today that enrollment has begun in a 2-Arm randomized Phase II study of carboplatin, paclitaxel plus REOLYSIN versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer.
Two community dental clinics that provide much-needed services to low-income people who lack access to care will receive a $10,000 grant from Delta Dental of Pennsylvania.
In a study to be presented on February 16 between 8 a.m., and 10 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, researchers will report findings that suggest comprehensive maternal hemorrhage protocols reduce utilization of blood products and improve patient safety.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bradley Philip Oneill, DO 148 13th St Sw, Largo, FL 33770-3127 Ph: (727) 581-8706 | Dr Bradley Philip Oneill, DO 148 13th St Sw, Largo, FL 33770-3127 Ph: (727) 581-8706 |
News Archive
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today celebrated the completion of renovations to its U.S. headquarters in Bridgewater, New Jersey with a ribbon-cutting ceremony.
Oncolytics Biotech Inc. announced today that enrollment has begun in a 2-Arm randomized Phase II study of carboplatin, paclitaxel plus REOLYSIN versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer.
Two community dental clinics that provide much-needed services to low-income people who lack access to care will receive a $10,000 grant from Delta Dental of Pennsylvania.
In a study to be presented on February 16 between 8 a.m., and 10 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, researchers will report findings that suggest comprehensive maternal hemorrhage protocols reduce utilization of blood products and improve patient safety.
› Verified 3 days ago
Philip Lee Shettle, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 13113 66th St, Largo, FL 33773 Phone: 727-674-2500 Fax: 727-674-2550 | |
Stacia H Goldey, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 148 13th St Sw, Largo, FL 33770 Phone: 727-581-8706 Fax: 727-588-2447 | |
Dr. Winston T Cope, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 148 13th St Sw, Largo, FL 33770 Phone: 727-642-0301 | |
Siddarth Rathi, MD, MBA Ophthalmology Medicare: Medicare Enrolled Practice Location: 148 13th St Sw, Largo, FL 33770 Phone: 727-581-8706 Fax: 727-588-2447 | |
Dr. Frank Seidl, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2770 E Bay Dr, Largo, FL 33771 Phone: 727-530-1425 | |
Robert Davis, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 148 13th St Sw, Largo, FL 33770 Phone: 727-581-8706 |